Abstract:
There is provided processes for preparing carvedilol dihydrogen phosphate hemihydrate, which processes include at least one of the steps of: (a) providing a solution of carvedilol in a mixture of organic solvent (s) and/or water; (b) adding a phosphonating agent to the reaction mixture of step (a); and (c) further processing to obtain carvedilol dihydrogen phosphate hemihydrate. There is also provided pharmaceutical compositions comprising carvedilol dihydrogen phosphate hemihydrate and processes for their preparation.
Abstract:
Processes for preparing desvenlafaxine and stable amorphous O-desmethylvenlafaxine succinate solid dispersions with one or more pharmaceutically acceptable carriers.
Abstract:
The present invention relates to composition of polyherbal transdermal patch comprising combination of natural herbal extracts as active ingredients and pharmaceutically acceptable excipients. The present invention relates to composition of polyherbal transdermal patch comprising combination of natural herbal extracts includes boswellia extract, evening primrose oil, blackcurrant seed oil, Ginger, Licorice, Cats claw and Devil's claw and other pharmaceutically acceptable excipients. The present invention also relates to composition of polyherbal transdermal patch comprising boswellia extract, evening primrose oil, blackcurrant seed oil, Ginger, Licorice, Cats claw and Devil's claw as natural herbal ingredients and pharmaceutically acceptable excipients for the treatment/management of pain. The present invention also relates to an efficient process for the preparation of polyherbal transdermal patch by using hot-melt coating technique (HMC), comprising the steps of melting, mixing, coating, laminating, cutting, pouching and labelling.
Abstract:
The present invention relates to matrix adhesive patch and its preparation. The present invention specifically relates to an analgesic matrix adhesive patch and its preparation. The present invention more specifically relates to a matrix patch adhesive preparation containing Camphor, Menthol and Methyl salicylate and process for the preparation thereof which delivers predetermined amount of drug continuously through skin and provide the temporary relief of minor aches & pains of muscles & joints associated with; Arthritis, Strains, Bruises & Sprains.
Abstract:
This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.
Abstract:
A peak current controlled switching voltage regulator system and method for providing a self-power down mode. An on-chip voltage regulator integrated into an on-chip digital logic circuit provides a core supply voltage to the on-chip digital logic circuit along with an off-chip inductor. An off-chip regulator connected to the on-chip digital logic circuit provides an external core supply voltage with respect to the on-chip digital logic circuit. A start-up circuit operates the on-chip voltage regulator in a self-power down mode for a pre-determined time period when the on-chip regulator is not connected to the off-chip inductor in order to maintain an equilibrium voltage supply with respect to the on-chip digital logic circuit.
Abstract:
The subject matter herein relates to computer software and client-server based applications and, more particularly, to a mobile business client. Some embodiments include one or more device-agnostic application interaction models and one or more device specific transformation services. Some such embodiments provide one or more of systems, methods, and software embodied at least in part in a device specific transformation service to transform channel agnostic application interaction models to and from device or device surrogate specific formats.
Abstract:
Allocating bits in an encoding scheme to reduce the number of bits required to send starting track information. In one embodiment a joint starting track indicator is sent with a frame to indicate the starting tracks for all subframes in the frame.
Abstract:
The present invention relates to the oral solid pharmaceutical composition comprising lamivudine or a pharmaceutically acceptable salt thereof with isomalt as a filler. The present invention also relate to the combination of lamivudine and other Anti-HIV agents. Thus, for example, the present invention provides a stable tablet formulation comprising lamivudine, isomalt, crospovidone, calcium stearate and opadry white.